ATUL Limited Posts 47% Growth in Q3 Consolidated Net Profit to ₹1.60 Billion

1 min read     Updated on 23 Jan 2026, 02:45 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

ATUL Limited reported impressive Q3 results with consolidated net profit surging 46.79% year-on-year to ₹1.60 billion from ₹1.09 billion. The strong performance demonstrates the specialty chemicals and pharmaceutical company's operational excellence and ability to generate robust returns while maintaining growth momentum across its business segments.

30705335

*this image is generated using AI for illustrative purposes only.

ATUL Limited has reported strong financial results for the third quarter, with consolidated net profit showing significant improvement compared to the same period in the previous year. The specialty chemicals and pharmaceutical company delivered robust performance across its business operations during the quarter.

Financial Performance Highlights

The company's consolidated net profit for Q3 reached ₹1.60 billion, representing a substantial increase from ₹1.09 billion recorded in the corresponding quarter of the previous year. This performance demonstrates the company's ability to generate strong returns and maintain growth momentum.

Financial Metric: Q3 Current Year Q3 Previous Year Growth (%)
Consolidated Net Profit: ₹1.60 billion ₹1.09 billion +46.79%

Business Performance Analysis

The year-on-year growth of 46.79% in consolidated net profit indicates strong operational performance and effective business execution by ATUL Limited during the quarter. This significant improvement in profitability reflects the company's continued focus on delivering value to stakeholders.

The substantial increase in net profit demonstrates ATUL Limited's resilience and ability to capitalize on market opportunities while maintaining operational efficiency. The company's performance in Q3 shows positive momentum in its core business segments.

Market Position

ATUL Limited's strong quarterly results reinforce its position as a significant player in the specialty chemicals and pharmaceutical sectors. The company's ability to deliver consistent growth in profitability highlights its competitive strengths and market positioning.

The robust financial performance in Q3 reflects ATUL Limited's strategic initiatives and operational excellence, positioning the company well for continued growth and value creation for its stakeholders.

like15
dislike

Atul Ltd Maintains Buy Rating at ₹8,500 Target Despite US Export Headwinds

2 min read     Updated on 09 Jan 2026, 07:35 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Brokerage maintains Buy rating on Atul Ltd with ₹8,500 target after facility visit to 1,350-acre Gujarat complex producing 900+ products. LER plant operates at 75-80% utilization with strong domestic windmill demand, though US exports face tariff challenges. FY27E EPS trimmed 5% for margin pressures, but competitive 2,4-D exports and 223-member R&D team support long-term outlook.

29513118

*this image is generated using AI for illustrative purposes only.

A leading brokerage has reaffirmed its Buy rating on Atul Ltd with a target price of ₹8,500 following an extensive visit to the company's integrated manufacturing complex in Atul, Gujarat. The assessment comes after meetings with key management personnel, including Vivek Gadre, President (Corporate Strategy) and Whole-time Director.

Manufacturing Infrastructure and Capabilities

Atul's integrated complex represents a significant industrial asset spanning over 1,350 acres, originally purchased in 1947. The facility demonstrates the company's manufacturing prowess through its diverse production capabilities.

Parameter Details
Total Area 1,350 acres
Products Manufactured Over 900 products
Formulations 400 formulations
Acquisition Year 1947
Divisions Four dedicated zones

The complex operates across four distinct zones, each dedicated to specific divisions. Notably, products under the aromatics division, such as p-Cresol, are manufactured at separate locations. The facility maintains robust environmental compliance through its own Effluent Treatment Plant (ETP) and a separate central ETP system.

Operational Performance and Market Dynamics

The liquid epoxy resin (LER) plant currently operates at 75-80% utilization on debottlenecked capacity. Domestic demand remains strong, particularly from windmill applications, though US exports face challenges due to tariff impacts.

Business Segment Current Status
LER Plant Utilization 75-80% of debottlenecked capacity
Domestic Demand Driver Windmill applications
US Export Status Impacted by tariffs
ECH Availability Abundant supply expected

The company benefits from abundant Epichlorohydrin (ECH) availability, with new capacities coming online in South-east Asia. Additionally, Atul maintains captive power plants that cater to the overall energy requirements of the integrated complex, including the caustic soda plant operations.

Competitive Positioning and Innovation

Atul holds a competitive advantage in 2,4-D exports to the US market, demonstrating its strong market position in specialty chemicals. The company's commitment to innovation is evident through its substantial R&D infrastructure.

R&D Metrics Details
R&D Team Size 223 members
Patent Applications Filed 18 patents
Patents Granted 9 patents

Revised Financial Outlook

The brokerage has made modest adjustments to its financial projections, trimming FY27E EPS estimates by approximately 5%. This revision accounts for near-term EBITDA margin pressure resulting from weaker export volumes to the US market. The analysis now rolls over to December 2027E EPS for valuation purposes.

Despite these near-term challenges, the brokerage maintains its Buy recommendation with a target price of ₹8,500, reflecting confidence in Atul's long-term prospects and competitive positioning in the specialty chemicals sector.

like18
dislike

More News on Atul